Teyi Pharmaceutical Group Co Ltd (002728) - Total Assets

Latest as of March 2026: CN¥2.33 Billion CNY ≈ $340.67 Million USD

Based on the latest financial reports, Teyi Pharmaceutical Group Co Ltd (002728) holds total assets worth CN¥2.33 Billion CNY (≈ $340.67 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Teyi Pharmaceutical Group Co Ltd - Total Assets Trend (2009–2025)

This chart illustrates how Teyi Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Teyi Pharmaceutical Group Co Ltd (002728) market capitalisation for the company's overall valuation and market capitalisation.

Teyi Pharmaceutical Group Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Teyi Pharmaceutical Group Co Ltd's total assets of CN¥2.33 Billion consist of 37.1% current assets and 62.9% non-current assets. Review 002728 total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	5.5%
Accounts Receivable	CN¥260.17 Million	11.3%
Inventory	CN¥237.63 Million	10.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥148.77 Million	6.4%
Goodwill	CN¥517.60 Million	22.4%

Asset Composition Trend (2009–2025)

This chart illustrates how Teyi Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 002728 stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Teyi Pharmaceutical Group Co Ltd's current assets represent 37.1% of total assets in 2025, a decrease from 68.9% in 2009.
Cash Position: Cash and equivalents constituted 5.5% of total assets in 2025, down from 10.3% in 2009.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 10.0% in 2009.
Asset Diversification: The largest asset category is goodwill at 22.4% of total assets.

Teyi Pharmaceutical Group Co Ltd Competitors by Total Assets

Key competitors of Teyi Pharmaceutical Group Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Teyi Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.01	2.02	0.96
Quick Ratio	1.43	1.31	0.59
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥448.23 Million	CN¥393.21 Million	CN¥-24.45 Million

Teyi Pharmaceutical Group Co Ltd - Advanced Valuation Insights

This section examines the relationship between Teyi Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.58
Latest Market Cap to Assets Ratio	0.31
Asset Growth Rate (YoY)	-3.7%
Total Assets	CN¥2.31 Billion
Market Capitalization	$724.09 Million USD

Valuation Analysis

Below Book Valuation: The market values Teyi Pharmaceutical Group Co Ltd's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Teyi Pharmaceutical Group Co Ltd's assets decreased by 3.7% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Teyi Pharmaceutical Group Co Ltd (2009–2025)

The table below shows the annual total assets of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.31 Billion ≈ $338.23 Million	-3.73%
2024-12-31	CN¥2.40 Billion ≈ $351.32 Million	-4.45%
2023-12-31	CN¥2.51 Billion ≈ $367.68 Million	-1.30%
2022-12-31	CN¥2.55 Billion ≈ $372.50 Million	+23.20%
2021-12-31	CN¥2.07 Billion ≈ $302.35 Million	-8.42%
2020-12-31	CN¥2.26 Billion ≈ $330.14 Million	-0.03%
2019-12-31	CN¥2.26 Billion ≈ $330.24 Million	+9.15%
2018-12-31	CN¥2.07 Billion ≈ $302.55 Million	+7.19%
2017-12-31	CN¥1.93 Billion ≈ $282.27 Million	+20.32%
2016-12-31	CN¥1.60 Billion ≈ $234.60 Million	+0.32%
2015-12-31	CN¥1.60 Billion ≈ $233.85 Million	+93.57%
2014-12-31	CN¥825.60 Million ≈ $120.81 Million	+82.03%
2013-12-31	CN¥453.54 Million ≈ $66.37 Million	+16.83%
2012-12-31	CN¥388.22 Million ≈ $56.81 Million	+37.08%
2011-12-31	CN¥283.21 Million ≈ $41.44 Million	+12.06%
2010-12-31	CN¥252.73 Million ≈ $36.98 Million	+33.26%
2009-12-31	CN¥189.65 Million ≈ $27.75 Million	--

About Teyi Pharmaceutical Group Co Ltd

SHE:002728 China Drug Manufacturers - Specialty & Generic

Market Cap

$724.09 Million

CN¥4.95 Billion CNY

Market Cap Rank

#10480 Global

#2837 in China

Share Price

CN¥9.64

Change (1 day)

+3.88%

52-Week Range

CN¥8.00 - CN¥15.21

All Time High

CN¥129.24